Jubilant Life's stock ended at Rs 211.60, up 2.84 per cent on the BSE. During the day, the scrip surged 6.92 per cent to Rs 220 -- its 52-week high.
At the NSE, the stock settled 2.68 per cent higher at Rs 211.
The company is a one amongst the largest manufacturers of Vitamin B3 (Niacin & Niacinamide) in the world.
In a BSE filing, it said the "price increase of 9 per cent for Niacinamide with immediate effect" is for "non-contract customers and wherever existing contracts permit".
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
